Media Summary: In this video, Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses the role of donor lymphocyte ... Dr Josep Ribera talks to ecancer about his talk at ALL Assembly 2021. He begins by saying that 20-30% of ALL transplant ... Christoph Schmid, MD, University of Augsburg, Augsburg, Germany, comments on the use of donor lymphocyte infusion (

Practical Considerations For Dli After - Detailed Analysis & Overview

In this video, Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses the role of donor lymphocyte ... Dr Josep Ribera talks to ecancer about his talk at ALL Assembly 2021. He begins by saying that 20-30% of ALL transplant ... Christoph Schmid, MD, University of Augsburg, Augsburg, Germany, comments on the use of donor lymphocyte infusion ( In this video, Nico Gagelmann, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, discusses the ... Antonio Pérez-Martínez, MD, PhD, La Paz University Hospital, Madrid, Spain, comments on the safety and efficacy of ... Preparing Students For The DLI OPI Testing

Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses donor-lymphocyte infusion ( Charles Craddock, CBE, FRCP(UK), FRCPath, DPhil, University of Birmingham, Birmingham, UK, comments on the Phase Ib/II ... The 2021 - 2022 Dual Language/Immersion (DL/I) Webinar Series is focused on sharing program and pedagogical best practices.

Photo Gallery

Practical considerations for DLI after haploidentical SCT
Post-HSCT management of ALL - Adult ALL perspective
The use of DLI to prevent relapse
DLI after allogeneic stem cell transplantation: where do we stand?
The role of DLI & molecular monitoring in patients with myelofibrosis who relapse after SCT
DLI After You Stop Working — How Long SSDI Insurance Status Can Last   (Mini Q&A)
What is a DLI
Safety and efficacy of CD45RA+-depleted DLI in pediatric stem cell transplant recipients
Preparing Students For The DLI OPI Testing
DLI following haploHCT PTCy relapse
Phase Ib/II trial of siremadlin alone or in combination with DLI in high-risk AML post-alloSCT
DLi P&C video 3 Sharpen your saw 20220117
View Detailed Profile
Practical considerations for DLI after haploidentical SCT

Practical considerations for DLI after haploidentical SCT

In this video, Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses the role of donor lymphocyte ...

Post-HSCT management of ALL - Adult ALL perspective

Post-HSCT management of ALL - Adult ALL perspective

Dr Josep Ribera talks to ecancer about his talk at ALL Assembly 2021. He begins by saying that 20-30% of ALL transplant ...

The use of DLI to prevent relapse

The use of DLI to prevent relapse

Christoph Schmid, MD, University of Augsburg, Augsburg, Germany, comments on the use of donor lymphocyte infusion (

DLI after allogeneic stem cell transplantation: where do we stand?

DLI after allogeneic stem cell transplantation: where do we stand?

Speaker: Panagiotis Tsirigotis.

The role of DLI & molecular monitoring in patients with myelofibrosis who relapse after SCT

The role of DLI & molecular monitoring in patients with myelofibrosis who relapse after SCT

In this video, Nico Gagelmann, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, discusses the ...

DLI After You Stop Working — How Long SSDI Insurance Status Can Last   (Mini Q&A)

DLI After You Stop Working — How Long SSDI Insurance Status Can Last (Mini Q&A)

DLI After

What is a DLI

What is a DLI

DLI

Safety and efficacy of CD45RA+-depleted DLI in pediatric stem cell transplant recipients

Safety and efficacy of CD45RA+-depleted DLI in pediatric stem cell transplant recipients

Antonio Pérez-Martínez, MD, PhD, La Paz University Hospital, Madrid, Spain, comments on the safety and efficacy of ...

Preparing Students For The DLI OPI Testing

Preparing Students For The DLI OPI Testing

Preparing Students For The DLI OPI Testing

DLI following haploHCT PTCy relapse

DLI following haploHCT PTCy relapse

Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses donor-lymphocyte infusion (

Phase Ib/II trial of siremadlin alone or in combination with DLI in high-risk AML post-alloSCT

Phase Ib/II trial of siremadlin alone or in combination with DLI in high-risk AML post-alloSCT

Charles Craddock, CBE, FRCP(UK), FRCPath, DPhil, University of Birmingham, Birmingham, UK, comments on the Phase Ib/II ...

DLi P&C video 3 Sharpen your saw 20220117

DLi P&C video 3 Sharpen your saw 20220117

This

DLI 2nd Quarter Webinar Building a DLI Program

DLI 2nd Quarter Webinar Building a DLI Program

The 2021 - 2022 Dual Language/Immersion (DL/I) Webinar Series is focused on sharing program and pedagogical best practices.